4.7 Review

Tissue protein biomarker candidates to predict progression of esophageal squamous cell carcinoma and precancerous lesions

Journal

ANNALS OF THE NEW YORK ACADEMY OF SCIENCES
Volume 1434, Issue 1, Pages 59-69

Publisher

WILEY
DOI: 10.1111/nyas.13863

Keywords

esophageal squamous cell carcinoma; precancerous lesions; protein biomarker candidates; screening; prognosis; disease progression

Funding

  1. National Key Research and Development Program of China [2016YFC0901400]
  2. National Natural Science Foundation of China [81573224]
  3. Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences [2017PT32001, 2016ZX310178]
  4. Youth Research Fund by Peking Union Medical College [2017310044]

Ask authors/readers for more resources

Esophageal squamous cell carcinoma (ESCC) is one of the most predominant malignancies worldwide. The 5-year survival rate is still relatively low due to few symptoms presenting with the early disease, diagnosis at middle to late stage, and high risk of recurrence after therapy. Novel protein biomarkers for early detection and treatment of ESCC have the potential to reduce incidence and mortality rates, and significantly prolong the 5-year survival rate. To date, several ESCC biomarkers are being investigated for screening, diagnosis, and treatment to decrease the disease burden. This review summarizes recent developments in candidate protein biomarkers for early diagnosis, predictors for precancerous disease progression, and prognosis of ESCC. Protein biomarkers that enable identification of the different pathologic grades of ESCC will need to be identified. ESCC biomarkers have the potential to improve screening and treatment strategies; multicenter prospective studies with large sample sizes will be required to confirm the usefulness of these candidate biomarkers.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Clinical Neurology

Sex Differences in Short-Term and Long-Term Outcomes Among Patients With Acute Ischemic Stroke in China

Meng Wang, Chun-Juan Wang, Hong-Qiu Gu, Xia Meng, Yong Jiang, Xin Yang, Jing Zhang, Yun-Yun Xiong, Xing-Quan Zhao, Li-Ping Liu, Yi-Long Wang, Yong-Jun Wang, Zi-Xiao Li

Summary: This study aims to explore the sex differences in stroke outcomes among Chinese patients. The results showed that female patients with acute ischemic stroke had higher rates of unfavorable functional outcomes at three months, especially among those aged 65 years and older. However, there were no significant sex differences in stroke recurrence, mortality, and unfavorable functional outcomes at other time points.

STROKE (2022)

Article Clinical Neurology

Short-term effect of PM2.5 on stroke in susceptible populations: A case-crossover study

Meng Wang, Ying Han, Chun-Juan Wang, Tao Xue, Hong-Qiu Gu, Kai-Xuan Yang, Heng-Yi Liu, Man Cao, Xia Meng, Yong Jiang, Xin Yang, Jing Zhang, Yun-Yun Xiong, Xing-Quan Zhao, Li-Ping Liu, Yi-Long Wang, Tian-Jia Guan, Zi-Xiao Li, Yong-Jun Wang

Summary: Short-term exposure to PM2.5 is significantly associated with hospital admission for stroke in individuals with pre-existing medical histories, especially in older or female patients with AF. Preventive measures to reduce PM2.5 concentrations are particularly important in individuals with other medical co-morbidities.

INTERNATIONAL JOURNAL OF STROKE (2023)

Article Clinical Neurology

Low LDL-C level and intracranial haemorrhage risk after ischaemic stroke: a prospective cohort study

Jie Xu, Zimo Chen, Meng Wang, Jinglin Mo, Jing Jing, Gulbahram Yalkun, Liye Dai, Xia Meng, Hao Li, Zixiao Li, Yongjun Wang

Summary: This study aimed to investigate the impact of low-density lipoprotein cholesterol (LDL-C) levels on the risk of intracranial hemorrhage in stroke patients. The results showed a significantly increased risk of intracranial hemorrhage in the subgroups with LDL-C levels of 1.40-1.79 mmol/L and <1.40 mmol/L.

STROKE AND VASCULAR NEUROLOGY (2023)

Article Clinical Neurology

Rationale and design of the GOLDEN BRIDGE II: a cluster-randomised multifaceted intervention trial of an artificial intelligence-based cerebrovascular disease clinical decision support system to improve stroke outcomes and care quality in China

Zixiao Li, Xinmiao Zhang, Lingling Ding, Jing Jing, Hong-Qiu Gu, Yong Jiang, Xia Meng, Chunying Du, Chunjuan Wang, Meng Wang, Man Xu, Yanxu Zhang, Meera Hu, Hao Li, Xiping Gong, Kehui Dong, Xingquan Zhao, Yilong Wang, Liping Liu, Ying Xian, Eric Peterson, Gregg C. Fonarow, Lee H. Schwamm, Yongjun Wang

Summary: This article describes the design and methods of a study investigating the impact of cerebrovascular disease AI-CDSS on the clinical outcomes and stroke care quality in China. The study randomly assigned 80 hospitals to either the AI-CDSS intervention group or the control group. The primary outcome is the occurrence of new vascular events at 3 months after stroke onset.

STROKE AND VASCULAR NEUROLOGY (2023)

No Data Available